BioTalk is a news hub brought to you by Bird & Bird's International Life Sciences & Healthcare Group. Read more about us >

COVID-19: Our series of regulatory legislation trackers for the Life Sciences & Healthcare industry

Biotech 1 min
July 30, 2020

COVID-19 presents an unprecedented challenge to the global life sciences industry.  Members of our International Life Sciences & Healthcare team, lawyers who have a wealth of hands-on experience and strong relationships with regulatory bodies, have worked together to provide an update in the form of a Q&A for each of the countries we are located.  This update aims to provide guidance on the responses of EU and Asia-Pac regulators in the areas of clinical trials, medical devices, market access, public procurement and compulsory licensing.

Today we release the latest in our series, focusing on Market Access, please click on the link below to view this tracker:

Other trackers available in this series:

  • COVID-19: Legislation Tracker for Medical Devices, read here
  • COVID-19: Legislation Tracker for Clinical Trials, read here
  • COVID-19: Legislation Tracker for Public Procurement, read here
  • COVID-19: Legislation Tracker for State Use/Compulsory Licensing, read here

Related articles

UK Supreme Court hearing appeal over permitted breadth of patent claims
Yesterday and today the Supreme Court has been hearing an appeal concerning Regeneron's...
Transfer of value in France: the long-awaited “anti-gift” decree has finally been published
The French so-called “anti-gift” provisions strictly frame the conditions under which companies in the...
Bird & Bird secures win in preliminary injunction patent case before the Düsseldorf Courts
On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical...
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.